SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Jun 30, 2015
Trial Information
Current as of May 07, 2025
Completed
Keywords
ClinConnect Summary
Background to the research: Sarcopenia is a multifactorial geriatric syndrome with a prevalence ranging between 1 and 29% depending on age. It is defined by progressive, generalised loss of skeletal muscle, mass, force and function.
Problem statement and objectives: To confirm a simple, reproducible, screening tool, which is easy to use in the general practitioner's surgery is one of the challenges of the future.
The primary objective is to assess the sensitivity and specificity of the study screening test, the SARC-F, at a predetermined threshold of \>=4 and to change this threshold usin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women who are 65-year old or older consulting a general practitioner, regardless of initial reason for the consultation.
- • Patients agreeing to take part in the study after clear, true and appropriate information has been provided, giving their signed consent and having been given by hand a patient information sheet.
- exclusion criteria:
- • Patients with cognitive disorders suffering from major incapacity making understanding the study or signing the informed consent impossible.
- • Patients not affiliated to a Social Security system.
- • Patients suffering from acute functional problems interfering with the tests being performed (incapacity, malformation of the arm, plaster or splint).
- • Patients institutionalised in nursing homes or subacute care
- • Patients who use a technical aid for walking, unless this aid is a walking stick
- • Patients not being followed up in a general practitioner's surgery (absence of information required to carry out the analytical part)
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cozzano, Corse, France
Peri, Corse, France
Patients applied
Trial Officials
Stéphane M SCHNEIDER
Principal Investigator
schneider.s@chu-nice.fr
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials